Evaluation of the Breast Cancer Patient Support System Application Softwere for Breast Cancer Patients on Drug Therapies.

Evaluation of the Breast Cancer Patient Support System Application Softwere for Breast Cancer Patients on Drug Therapies. - BPSS study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000032104

Enrollment

100

Registered

2018-04-04

Start date

2018-04-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

BPSS application without BPSS application(conventional support)

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Breast cancer outpatients on the first line antheracycline-/taxane-based chemotherapies Patients who hope to participate in this study

Exclusion criteria

Exclusion criteria: Patients with cognitive dysfunction or too severe physical condition Inability to read and write Japanese Patients who are not familiar with smartphone or tablet computer Unavailable internet facility for BPSS use Patients considered by primary doctors as inappropriateness of participation

Design outcomes

Primary

Measure	Time frame
HADS as known as Hospital anxiety and depression scale	—

Secondary

Measure	Time frame
HRQOL(EQ-5D),health lieteracy (HLS-14) , the number of ADR records(items,frequency,severity), App addherence	—

Countries

Japan

Contacts

Public ContactSatoko Handa

Showa University School of Pharmacy

shanda@pharm.showa-u.ac.jp03-3784-8440

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026